Xu-fen Ding
CAS Key Laboratory Of Nutrition
Shanghai, 200031, China
Shanghai, 200031, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Correction to: PPDPF promotes lung adenocarcinoma progression via inhibiting apoptosis and NK cell-mediated cytotoxicity through STAT3.
Journal: Oncogene
Published: July 26, 2023
PPDPF Promotes the Development of Mutant KRAS-Driven Pancreatic Ductal Adenocarcinoma by Regulating the GEF Activity of SOS1.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: April 28, 2022
ARID2 mitigates hepatic steatosis via promoting the ubiquitination of JAK2.
Journal: Cell death and differentiation
Published: April 08, 2022
Targeting USP9X-AMPK Axis in ARID1A-Deficient Hepatocellular Carcinoma.
Journal: Cellular and molecular gastroenterology and hepatology
Published: September 27, 2021
PPDPF alleviates hepatic steatosis through inhibition of mTOR signaling.
Journal: Nature communications
Published: June 12, 2020
Chromatin remodeling factor ARID2 suppresses hepatocellular carcinoma metastasis via DNMT1-Snail axis.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: February 20, 2020
Showing 1-9 of 9
Last Updated: 09/26/2026